“Chimeric Antigen Receptor T-Cell Manufacturing Turnaround: Vein-to-Vein Time As a Clinical Variable”. 2023. Translational Medicine & Therapeutics Journal 2 (1): 1-9. https://doi.org/10.5281/zenodo.22649019.